Our Region thrives because of the support of investors, elevators, an extensive startup support system, and established and prominent research hubs. Innovation in the Region is inclusive - it's happening across diverse sectors and includes social, cultural, sustainable and indigenous innovation.
The Edmonton Region is a place to challenge boundaries, unlock your potential, and achieve the unthinkable.
Expert-level consultation on productivity and quality enhancement for the energy, manufacturing, fabrication, and construction industries. Typical services include: process, consumable and/or equipment evaluations, comparisons, demonstrations and recommendations for welding, cutting, fit-up and material handling; welding procedure development and/or optimization; and facilitating vendor/end-user relationships in a commercially-unbiased and technically-focused manner.
Edmonton Unlimited leverages, unites and promotes home-grown innovation as a gateway to solving the world’s most pressing problems. We harness the power of the private sector, ground-breaking academic research and purpose-driven investment to build a shared prosperity and open international markets. From sustainable climate solutions to public health and digital education, Edmonton is a leading global centre for inspiration, ingenuity and inclusion.
Innovation Masterminds (imYEG) is a pre-accelerator, designed to facilitate the launch of successful commercial ventures from academia.
The Kaye Edmonton Clinic (KEC) is home to nearly 100 specialized outpatient clinics, conveniently located under one roof.
Higher Learning/research
The FPDC is a modern, 65,000 square foot pilot plant and product development laboratory equipped with more than $20,000,000 in equipment that supports food product innovation along the full development and commercialization continuum. Clients can access technical consultation, benchtop development, pilot plant development, scale-up, business development, applied research and interim processing services.
Through the Li Ka Shing Applied Virology Institute (LKSAVI), the LKSIoV further supports discoveries in vaccines, treatments, and diagnostic tests for viral and selected other diseases affecting humans. The institute has become a leader in using artificial intelligence (AI) for computational drug design. The acquisition of a Blue Gene/Q, the fastest supercomputer in Canada, allows for state-of-art drug design aimed at specific therapeutic targets in various diseases currently plaguing Canadians, as well as millions of people worldwide.